144 related articles for article (PubMed ID: 18460662)
1. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.
Herzog CA
JAMA; 2008 May; 299(17):2023-5. PubMed ID: 18460662
[No Abstract] [Full Text] [Related]
2. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
Kalra A; Shroff GR; Erlien D; Gilbertson DT; Herzog CA
JACC Cardiovasc Imaging; 2014 Feb; 7(2):206-7. PubMed ID: 24524748
[No Abstract] [Full Text] [Related]
3. Ultrasound contrast agents: balancing safety versus efficacy.
Main ML; Goldman JH; Grayburn PA
Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic instability after receiving intravenous Perflutren for contrast echocardiography in an elderly female.
Blokh I; Ganem A; Bonaros EP; Stephen BD; Steinberg B; Rosen SE
Echocardiography; 2004 Oct; 21(7):613-5. PubMed ID: 15488089
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound contrast agent safety: from anecdote to evidence.
Main ML
JACC Cardiovasc Imaging; 2009 Sep; 2(9):1057-9. PubMed ID: 19761982
[No Abstract] [Full Text] [Related]
6. Perflutren-Induced Angioedema.
Gupta A; Harris S; Naina H
Echocardiography; 2015 Aug; 32(8):1329. PubMed ID: 26192312
[No Abstract] [Full Text] [Related]
7. Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients.
Abdelmoneim SS; Bernier M; Scott CG; Dhoble A; Ness SA; Hagen ME; Moir S; McCully RB; Pellikka PA; Mulvagh SL
JACC Cardiovasc Imaging; 2009 Sep; 2(9):1048-56. PubMed ID: 19761981
[TBL] [Abstract][Full Text] [Related]
8. Safety profile of ultrasound enhancing agents in echocardiography.
Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
[TBL] [Abstract][Full Text] [Related]
9. Sudden death after intravenous administration of a perflutren contrast agent: a case of pseudocomplication?
Mahjoub H; Roméo P; Leung TK; Burelle D; Cartier R; Basmadjian AJ
J Am Soc Echocardiogr; 2009 Jun; 22(6):753.e5-8. PubMed ID: 19269782
[TBL] [Abstract][Full Text] [Related]
10. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML
J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124
[TBL] [Abstract][Full Text] [Related]
11. Does contrast echocardiography with Optison induce myocardial necrosis in humans?
Borges AC; Walde T; Reibis RK; Grohmann A; Ziebig R; Rutsch W; Schimke I; Baumann G
J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1080-6. PubMed ID: 12373250
[TBL] [Abstract][Full Text] [Related]
12. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?
Knebel F; Schimke I; Eddicks S; Walde T; Ziebig R; Schattke S; Baumann G; Borges AC
Cardiovasc Ultrasound; 2005 Aug; 3():21. PubMed ID: 16107209
[TBL] [Abstract][Full Text] [Related]
13. Safety With Echocardiographic Contrast Agents.
Muskula PR; Main ML
Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
[TBL] [Abstract][Full Text] [Related]
14. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.
Hauben M; Hung EY; Hanretta KC; Bangalore S; Snow V
Drug Saf; 2015 Nov; 38(11):1127-39. PubMed ID: 26242615
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent.
Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH
JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713
[TBL] [Abstract][Full Text] [Related]
16. Safety of contrast dobutamine stress echocardiography: a single center experience.
Timperley J; Mitchell AR; Thibault H; Mirza IH; Becher H
J Am Soc Echocardiogr; 2005 Feb; 18(2):163-7. PubMed ID: 15682054
[TBL] [Abstract][Full Text] [Related]
17. Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction.
Nucifora G; Marsan NA; Siebelink HM; van Werkhoven JM; Schuijf JD; Schalij MJ; Poldermans D; Holman ER; Bax JJ
Eur J Echocardiogr; 2008 Nov; 9(6):816-8. PubMed ID: 18635517
[TBL] [Abstract][Full Text] [Related]
18. Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk.
Goldberg YH; Ginelli P; Siegel R; Ostfeld RJ; Schaefer M; Spevack DM
Cardiology; 2012; 122(2):119-25. PubMed ID: 22813648
[TBL] [Abstract][Full Text] [Related]
19. Contrast echocardiography: safety in numbers.
Main ML
Cardiology; 2012; 122(4):248-50. PubMed ID: 22906912
[No Abstract] [Full Text] [Related]
20. Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children?
Piskunowicz M; Kosiak W; Irga N
Ultraschall Med; 2011 Feb; 32(1):83-6. PubMed ID: 21305439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
